Medindia LOGIN REGISTER
Medindia
Advertisement

Novo to Launch Once-a-Day Insulin Injection Tresiba in India

by Kathy Jones on September 3, 2013 at 9:39 PM
 Novo to Launch Once-a-Day Insulin Injection Tresiba in India

Danish drugmaker Novo Nordisk revealed that it will soon be launching its long-lasting insulin injection, Tresiba, in India for type 1 and type 2 diabetes patients.

The once-a-day jab can provide insulin action for up to 42 hours, allowing diabetics to day-to-day dosing time when needed without raising the risk of hypoglycaemia. The injection will come in form of a prefilled pen and can enable a dosage of up to 80 units in a single use. The company said that it will be revealing the pricing for Tresiba at the time of its launch.

Advertisement

"Tresiba (insulin degludec)-- a new basal insulin for adult patients with type 1 and type 2 diabetes to be available in India as a new treatment option. We are through with clinical trials and have received the necessary approvals. We hope to launch it by the end of this year", Novo Nordisk India Managing Director Melvin D'souza said.



Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Diabetes News

Increased Type 2 Diabetes Risk in Children
The rising incidence of type 2 diabetes among children underscores a significant and worrying health shift.
Kick Smoking, Cut Your Diabetes Risk By Half
Engaging in smoking also heightens the likelihood of complications associated with diabetes, including cardiovascular disease, kidney failure, and blindness.
Australian Guidelines Unveiled for Diabetes-Related Foot Disease Care
Recently compiled guidelines originating in Australia for foot diseases related to diabetes have been consolidated.
Diabetes and Air Pollution: A Dangerous Duo for Health Complications
An expert emphasized the significance of protecting diabetic patients from the increasing levels of air pollution.
India Secures Second Place in Global Diabetes Estimates
Factors such as dining out, industrialization, migration to urban areas, and other elements contribute to the heightened susceptibility of Indians to diabetes.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Novo to Launch Once-a-Day Insulin Injection Tresiba in India Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests